There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Enlivex (ENLV – Research Report), Evolus (EOLS – Research Report) and Rallybio (RLYB – Research Report) with bullish sentiments.
Enlivex (ENLV)
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Enlivex, with a price target of $12.00. The company’s shares closed last Wednesday at $1.96.
According to TipRanks.com, Selvaraju is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Enlivex with a $12.00 average price target.
See the top stocks recommended by analysts >>
Evolus (EOLS)
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Evolus today and set a price target of $27.00. The company’s shares closed last Wednesday at $9.68.
According to TipRanks.com, Tsao is a 4-star analyst with an average return of
Currently, the analyst consensus on Evolus is a Strong Buy with an average price target of $22.80, implying a 124.9% upside from current levels. In a report issued on December 17, Mizuho Securities also maintained a Buy rating on the stock with a $20.00 price target.
Rallybio (RLYB)
In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Rallybio, with a price target of $17.00. The company’s shares closed last Wednesday at $2.75, close to its 52-week low of $1.72.
According to TipRanks.com, Kapoor is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Rallybio has an analyst consensus of Strong Buy, with a price target consensus of $15.67, implying a 433.0% upside from current levels. In a report issued on December 11, JMP Securities also reiterated a Buy rating on the stock with a $16.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ENLV:
